Skip to main content
All lobbying filings

S-3 Group

S-3 Group filed a Q4 report for Fresenius Kabi on January 15, 2026, reporting $30,000 in lobbying income.

Lobbying for Fresenius Kabi · Healthcare/pharmaceutical company

As filed: S-3 GROUP for FRESENIUS KABI.

All filings by S-3 Group · Everything Fresenius Kabi has reported

 Filing · LD-2 quarterly report Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 15, 2026
Income
$30,000
What the client paid this registrant for the period.
Client based in
District of Columbia

Official filing document

 Lobbyists on this filing 1
  • KRISTI REMINGTON
    Previously held: Deputy Assistant Attorney General, US Department of Justice; Senior Counsel, House Government Reform Committee

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 2
Health Issues

Eliminating Thickets to Improve Competition (S. 2276 and HR 3269); Medication Affordability and Patent Integrity Act (S. 2658)

Copyright/Patent/Trademark

Eliminating Thickets to Improve Competition (S. 2276 and HR 3269); Medication Affordability and Patent Integrity Act (S. 2658)

 Bills named in this filing 3

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem